{"id":11152,"date":"2024-04-22T10:13:36","date_gmt":"2024-04-22T10:13:36","guid":{"rendered":"https:\/\/cnls.sn\/?post_type=nos_actualites&amp;p=11152"},"modified":"2024-04-22T10:13:36","modified_gmt":"2024-04-22T10:13:36","slug":"un-vaccin-contre-le-vih-deux-grandes-compagnies-signent-un-partenariat-et-envisagent-des-essais","status":"publish","type":"post","link":"https:\/\/cnls.sn\/?p=11152","title":{"rendered":"Un vaccin contre le VIH :Deux grandes compagnies signent un partenariat et envisagent des essais"},"content":{"rendered":"<h2 style=\"text-align: justify;\"><span style=\"color: #000000;\">Naobios, une CDMO (Contract Development and Manufacturing Organization) qui offre des services pour le de\u0301veloppement de proce\u0301de\u0301s et la production selon les BPF (Bonnes Pratiques de Fabrication) de lots cliniques de m\u00e9dicaments \u00e0 base de virus, annonce aujourd&rsquo;hui la signature d&rsquo;un partenariat avec Sumagen, une soci\u00e9t\u00e9 de biotechnologie cor\u00e9o-canadienne d\u00e9veloppant un candidat vaccin contre le VIH (s\u00e9rotype 1). Naobios va r\u00e9aliser le d\u00e9veloppement de proc\u00e9d\u00e9s et la production de lots cliniques, pour les essais cliniques de phase II pilot\u00e9s par Sumagen. Les termes financiers n&rsquo;ont pas \u00e9t\u00e9 divulgu\u00e9s.<\/span><\/h2>\n<h2 style=\"text-align: justify;\"><span style=\"color: #000000;\">Selon l&rsquo;Organisation mondiale de la sant\u00e9 (OMS), environ 39 millions de personnes vivaient avec le VIH fin 2022. La mise au point d&rsquo;un vaccin contre le VIH est l&rsquo;un des plus grands d\u00e9fis de la recherche m\u00e9dicale, car cela n\u00e9cessite de bloquer de nombreuses formes g\u00e9n\u00e9tiques du VIH. Naobios pilotera le processus de production du candidat vaccin anti-VIH compl\u00e8tement inactiv\u00e9 de Sumagen en vue de confirmer son innocuit\u00e9 et son efficacit\u00e9 dans le cadre d&rsquo;un essai clinique de phase I. Naobios poursuivra ensuite le d\u00e9veloppement du proc\u00e9d\u00e9 afin de pr\u00e9parer le vaccin anti-VIH-1 pour les essais cliniques de phase II.<\/span><\/h2>\n<h2 style=\"text-align: justify;\"><span style=\"color: #000000;\">Gr\u00e2ce \u00e0 son site de production qui offre une bios\u00e9curit\u00e9 de niveau 3 (BSL3), Naobios dispose des capacit\u00e9s n\u00e9cessaires pour d\u00e9velopper et produire des vaccins contre des virus hautement pathog\u00e8nes, tels que le VIH, pour lesquels aucun vaccin n&rsquo;a encore \u00e9t\u00e9 identifi\u00e9. Naobios s\u2019occupera des activit\u00e9s de d\u00e9veloppement et d&rsquo;optimisation des processus pendant un an, puis du lancement de la production aux normes BPF pour les essais cliniques de phase II.<\/span><\/h2>\n<h2 style=\"text-align: justify;\"><span style=\"color: #000000;\">https:\/\/www.gazettelabo.fr\/breves\/15062Naobios-Sumagen-vaccin-VIH.html<\/span><\/h2>\n","protected":false},"excerpt":{"rendered":"<p>Naobios, une CDMO (Contract Development and Manufacturing Organization) qui offre des services pour le de\u0301veloppement de proce\u0301de\u0301s et la production selon les BPF (Bonnes Pratiques de Fabrication) de lots cliniques de m\u00e9dicaments \u00e0 base de virus, annonce aujourd&rsquo;hui la signature d&rsquo;un partenariat avec Sumagen, une soci\u00e9t\u00e9 de biotechnologie cor\u00e9o-canadienne d\u00e9veloppant un candidat vaccin contre le[&#8230;]\n","protected":false},"author":16,"featured_media":11158,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-11152","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Un vaccin contre le VIH :Deux grandes compagnies signent un partenariat et envisagent des essais - CNLS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cnls.sn\/?p=11152\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Un vaccin contre le VIH :Deux grandes compagnies signent un partenariat et envisagent des essais - CNLS\" \/>\n<meta property=\"og:description\" content=\"Naobios, une CDMO (Contract Development and Manufacturing Organization) qui offre des services pour le de\u0301veloppement de proce\u0301de\u0301s et la production selon les BPF (Bonnes Pratiques de Fabrication) de lots cliniques de m\u00e9dicaments \u00e0 base de virus, annonce aujourd&rsquo;hui la signature d&rsquo;un partenariat avec Sumagen, une soci\u00e9t\u00e9 de biotechnologie cor\u00e9o-canadienne d\u00e9veloppant un candidat vaccin contre le[...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cnls.sn\/?p=11152\" \/>\n<meta property=\"og:site_name\" content=\"CNLS\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-22T10:13:36+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cnls.sn\/wp-content\/uploads\/2024\/04\/vaccin-vih-une.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"259\" \/>\n\t<meta property=\"og:image:height\" content=\"194\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cnls.sn\/?p=11152#article\",\"isPartOf\":{\"@id\":\"https:\/\/cnls.sn\/?p=11152\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Un vaccin contre le VIH :Deux grandes compagnies signent un partenariat et envisagent des essais\",\"datePublished\":\"2024-04-22T10:13:36+00:00\",\"dateModified\":\"2024-04-22T10:13:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cnls.sn\/?p=11152\"},\"wordCount\":307,\"publisher\":{\"@id\":\"https:\/\/cnls.sn\/#organization\"},\"image\":{\"@id\":\"https:\/\/cnls.sn\/?p=11152#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cnls.sn\/wp-content\/uploads\/2024\/04\/vaccin-vih-une.jpg\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cnls.sn\/?p=11152\",\"url\":\"https:\/\/cnls.sn\/?p=11152\",\"name\":\"Un vaccin contre le VIH :Deux grandes compagnies signent un partenariat et envisagent des essais - CNLS\",\"isPartOf\":{\"@id\":\"https:\/\/cnls.sn\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cnls.sn\/?p=11152#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cnls.sn\/?p=11152#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cnls.sn\/wp-content\/uploads\/2024\/04\/vaccin-vih-une.jpg\",\"datePublished\":\"2024-04-22T10:13:36+00:00\",\"dateModified\":\"2024-04-22T10:13:36+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cnls.sn\/?p=11152#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cnls.sn\/?p=11152\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/cnls.sn\/?p=11152#primaryimage\",\"url\":\"https:\/\/cnls.sn\/wp-content\/uploads\/2024\/04\/vaccin-vih-une.jpg\",\"contentUrl\":\"https:\/\/cnls.sn\/wp-content\/uploads\/2024\/04\/vaccin-vih-une.jpg\",\"width\":259,\"height\":194},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cnls.sn\/?p=11152#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/cnls.sn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Un vaccin contre le VIH :Deux grandes compagnies signent un partenariat et envisagent des essais\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cnls.sn\/#website\",\"url\":\"https:\/\/cnls.sn\/\",\"name\":\"CNLS\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/cnls.sn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cnls.sn\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cnls.sn\/#organization\",\"name\":\"CNLS\",\"url\":\"https:\/\/cnls.sn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/cnls.sn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cnls.sn\/wp-content\/uploads\/2025\/12\/Logo_Cnls_bleu_page-0001.jpg\",\"contentUrl\":\"https:\/\/cnls.sn\/wp-content\/uploads\/2025\/12\/Logo_Cnls_bleu_page-0001.jpg\",\"width\":814,\"height\":536,\"caption\":\"CNLS\"},\"image\":{\"@id\":\"https:\/\/cnls.sn\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\/\/cnls.sn\/?author=16\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Un vaccin contre le VIH :Deux grandes compagnies signent un partenariat et envisagent des essais - CNLS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cnls.sn\/?p=11152","og_locale":"fr_FR","og_type":"article","og_title":"Un vaccin contre le VIH :Deux grandes compagnies signent un partenariat et envisagent des essais - CNLS","og_description":"Naobios, une CDMO (Contract Development and Manufacturing Organization) qui offre des services pour le de\u0301veloppement de proce\u0301de\u0301s et la production selon les BPF (Bonnes Pratiques de Fabrication) de lots cliniques de m\u00e9dicaments \u00e0 base de virus, annonce aujourd&rsquo;hui la signature d&rsquo;un partenariat avec Sumagen, une soci\u00e9t\u00e9 de biotechnologie cor\u00e9o-canadienne d\u00e9veloppant un candidat vaccin contre le[...]","og_url":"https:\/\/cnls.sn\/?p=11152","og_site_name":"CNLS","article_published_time":"2024-04-22T10:13:36+00:00","og_image":[{"width":259,"height":194,"url":"https:\/\/cnls.sn\/wp-content\/uploads\/2024\/04\/vaccin-vih-une.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cnls.sn\/?p=11152#article","isPartOf":{"@id":"https:\/\/cnls.sn\/?p=11152"},"author":{"name":"","@id":""},"headline":"Un vaccin contre le VIH :Deux grandes compagnies signent un partenariat et envisagent des essais","datePublished":"2024-04-22T10:13:36+00:00","dateModified":"2024-04-22T10:13:36+00:00","mainEntityOfPage":{"@id":"https:\/\/cnls.sn\/?p=11152"},"wordCount":307,"publisher":{"@id":"https:\/\/cnls.sn\/#organization"},"image":{"@id":"https:\/\/cnls.sn\/?p=11152#primaryimage"},"thumbnailUrl":"https:\/\/cnls.sn\/wp-content\/uploads\/2024\/04\/vaccin-vih-une.jpg","articleSection":["Uncategorized"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/cnls.sn\/?p=11152","url":"https:\/\/cnls.sn\/?p=11152","name":"Un vaccin contre le VIH :Deux grandes compagnies signent un partenariat et envisagent des essais - CNLS","isPartOf":{"@id":"https:\/\/cnls.sn\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cnls.sn\/?p=11152#primaryimage"},"image":{"@id":"https:\/\/cnls.sn\/?p=11152#primaryimage"},"thumbnailUrl":"https:\/\/cnls.sn\/wp-content\/uploads\/2024\/04\/vaccin-vih-une.jpg","datePublished":"2024-04-22T10:13:36+00:00","dateModified":"2024-04-22T10:13:36+00:00","breadcrumb":{"@id":"https:\/\/cnls.sn\/?p=11152#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cnls.sn\/?p=11152"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/cnls.sn\/?p=11152#primaryimage","url":"https:\/\/cnls.sn\/wp-content\/uploads\/2024\/04\/vaccin-vih-une.jpg","contentUrl":"https:\/\/cnls.sn\/wp-content\/uploads\/2024\/04\/vaccin-vih-une.jpg","width":259,"height":194},{"@type":"BreadcrumbList","@id":"https:\/\/cnls.sn\/?p=11152#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/cnls.sn\/"},{"@type":"ListItem","position":2,"name":"Un vaccin contre le VIH :Deux grandes compagnies signent un partenariat et envisagent des essais"}]},{"@type":"WebSite","@id":"https:\/\/cnls.sn\/#website","url":"https:\/\/cnls.sn\/","name":"CNLS","description":"","publisher":{"@id":"https:\/\/cnls.sn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cnls.sn\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/cnls.sn\/#organization","name":"CNLS","url":"https:\/\/cnls.sn\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/cnls.sn\/#\/schema\/logo\/image\/","url":"https:\/\/cnls.sn\/wp-content\/uploads\/2025\/12\/Logo_Cnls_bleu_page-0001.jpg","contentUrl":"https:\/\/cnls.sn\/wp-content\/uploads\/2025\/12\/Logo_Cnls_bleu_page-0001.jpg","width":814,"height":536,"caption":"CNLS"},"image":{"@id":"https:\/\/cnls.sn\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"","url":"https:\/\/cnls.sn\/?author=16"}]}},"jetpack_featured_media_url":"https:\/\/cnls.sn\/wp-content\/uploads\/2024\/04\/vaccin-vih-une.jpg","_links":{"self":[{"href":"https:\/\/cnls.sn\/index.php?rest_route=\/wp\/v2\/posts\/11152","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cnls.sn\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cnls.sn\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cnls.sn\/index.php?rest_route=\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/cnls.sn\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=11152"}],"version-history":[{"count":0,"href":"https:\/\/cnls.sn\/index.php?rest_route=\/wp\/v2\/posts\/11152\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cnls.sn\/index.php?rest_route=\/wp\/v2\/media\/11158"}],"wp:attachment":[{"href":"https:\/\/cnls.sn\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=11152"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cnls.sn\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=11152"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cnls.sn\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=11152"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}